Clara Y H Choi
Overview
Explore the profile of Clara Y H Choi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
614
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mendoza M, Azoulay M, Chang S, Gibbs I, Hancock S, Pollom E, et al.
Pract Radiat Oncol
. 2023 Feb;
13(3):e239-e245.
PMID: 36736621
Purpose: In patients with newly diagnosed glioblastoma (GBM), tumor margins of at least 20 mm are the standard of care. We sought to determine the pattern of tumor progression in...
2.
Rahimy E, Dudley S, von Eyben R, Pollom E, Seiger K, Modlin L, et al.
Am J Clin Oncol
. 2021 Oct;
44(11):588-595.
PMID: 34670228
Objectives: We investigated differences in quality of life (QoL) in patients enrolled on a phase I/II dose-escalation study of 3-fraction resection cavity stereotactic radiosurgery (SRS) for large brain metastases. Methods:...
3.
Azoulay M, Chang S, Gibbs I, Hancock S, Pollom E, Harsh G, et al.
Neuro Oncol
. 2020 Feb;
22(8):1182-1189.
PMID: 32002547
Background: We sought to determine the maximum tolerated dose (MTD) of 5-fraction stereotactic radiosurgery (SRS) with 5-mm margins delivered with concurrent temozolomide in newly diagnosed glioblastoma (GBM). Methods: We enrolled...
4.
Seiger K, Pendharkar A, Samghabadi P, Chang S, Cho N, Choi C, et al.
Acta Neurochir (Wien)
. 2018 Oct;
161(1):43-48.
PMID: 30328524
The development of cavernous malformations many years following conventionally fractionated brain irradiation is well recognized and commonly reported. However, cavernous malformation induction following stereotactic radiosurgery (SRS) is largely unreported. Herein,...
5.
Choi C, Wakelee H, Neal J, Pinder-Schenck M, Yu H, Chang S, et al.
Int J Radiat Oncol Biol Phys
. 2017 Aug;
99(1):16-21.
PMID: 28816142
Purpose: To determine the maximum tolerated dose (MTD) of vorinostat, a histone deacetylase inhibitor, given concurrently with stereotactic radiosurgery (SRS) to treat non-small cell lung cancer (NSCLC) brain metastases. Secondary...
6.
Pollom E, Fujimoto D, Wynne J, Seiger K, Modlin L, Jacobs L, et al.
Int J Radiat Oncol Biol Phys
. 2017 Jun;
98(1):123-130.
PMID: 28586949
Purpose: We report a longitudinal assessment of health-related quality of life (HRQOL) in patients with glioblastoma (GBM) treated on a prospective dose escalation trial of 5-fraction stereotactic radiosurgery (25-40 Gy...
7.
DAstous M, Ho A, Pendharkar A, Choi C, Soltys S, Gibbs I, et al.
J Neurooncol
. 2016 Oct;
131(1):177-183.
PMID: 27752881
Non-vestibular cranial nerve schwannomas (NVCNS) are rare lesions, representing <10 % of cranial nerve schwannomas. The optimal treatment for NVCNS is often derived from vestibular schwannomas experience. Surgical resection has...
8.
Zhang M, Ho A, DAstous M, Pendharkar A, Choi C, Thompson P, et al.
World Neurosurg
. 2016 Apr;
91:574-581.e1.
PMID: 27108030
Objective: Recurrent World Health Organization (WHO) grade II and III meningiomas have traditionally been treated by surgery alone, but early literature suggests that adjuvant stereotactic radiosurgery may greatly improve outcomes....
9.
Shultz D, Modlin L, Jayachandran P, von Eyben R, Gibbs I, Choi C, et al.
Int J Radiat Oncol Biol Phys
. 2015 Jul;
92(5):993-999.
PMID: 26194677
Purpose: To report the outcomes of repeat stereotactic radiosurgery (SRS), deferring whole-brain radiation therapy (WBRT), for distant intracranial recurrences and identify factors associated with prolonged overall survival (OS). Patients And...
10.
King M, Modlin L, Million L, Donaldson S, Gibbs I, Choi C, et al.
Technol Cancer Res Treat
. 2015 May;
15(3):472-9.
PMID: 25948323
Purpose: Current craniospinal irradiation (CSI) protocols do not include the parotid gland as an organ at risk, potentially leading to late effects of xerostomia and secondary parotid malignancies. We analyzed...